F3 and COVID-19: Regarding the molecular basis of NET-induced immunothrombus formation in COVID-19-infected patients, Skendros et al. [200] found increased plasma NETs, tissue factor (TF) activity, and soluble complements sC5b-9 in COVID-19 patients.